Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Anti-Monopoly Chief Promises Even Tougher Response To Violators

This article was originally published in PharmAsia News

Executive Summary

Those not yet subjected to China's recent crackdown against antitrust violations could still face even tougher responses by the government as it continues its probes while promising "heavy punches" to stem the behavior.

Those not yet subjected to China's recent crackdown against antitrust violations could still face even tougher responses by the government as it continues its probes while promising "heavy punches" to stem the behavior. Xu Kunlin, head of anti-monoply for the National Development and Reform Commission, the agency that regulates prices, added the tougher position would not be targeted only at foreign companies and would be expanded beyond makers of drugs and infant formula. Xu told a forum "heavy punches" would be used to stop monopolistic behavior in all sectors, particularly those with a direct impact on the average Chinese. (Click here for more)

"Companies Treated Equally In Probe Of Anti-Monopoly Practice" - Shanghai Daily (China) (9/25/2013)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC085562

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel